Skip to content

A prospective single-blinded randomized multi-center clinical trial comparing the clinical efficacy and patient acceptability of open selective haemorrhoidopexy with stapled haemorrhoidopexy

A prospective single-blinded randomized multi-center clinical trial comparing the clinical efficacy and patient acceptability of open selective haemorrhoidopexy with stapled haemorrhoidopexy - PILE STOP Study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39498
Enrollment
186
Registered
2013-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

haemorrhoids piles

Interventions

open selective haemorrhoidopexy versus circular stapled haemorrhoidopexy

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age above 18 years;Symptoms of haemorrhoidal disease 2nd to 4th grade. In case of 2nd grade haemorrhoidal disease, at least two attempts of Barron ligation must have preceded;Primary or recurrent haemorrhoidal disease;Written informed consent

Exclusion criteria

Exclusion criteria: Acute presentation (not elective) Concurrent untreated or recurrent colorectal cancer Concomitant anorectal diseases (fistula, abscess, fissure, polyps) Prior endoscopic or surgical treatment of haemorrhoids within the past 6 months Active inflammatory bowel disease Previous major anorectal surgery A history of faecal incontinence Presence of severe rectal pain ASA >3 The patient is uncooperative or is not capable to return for routine outpatient follow-up On Coumarine derivate anticoagulation or history of coagulopathy On immunosuppressant medication Pregnancy Non-consenting patients Unwilling for randomisation

Design outcomes

Primary

MeasureTime frame
Primary endpoint is recurrence after two years.

Secondary

MeasureTime frame
Secondary Objectives: - Postoperative pain (VAS Score) - Early complications within 6 weeks postoperative: urinary retention, obstipation, incontinence - Complaints of urgency, tenesmus, pruritus - Patient satisfaction (VAS Score) - Operating time - Time of hospitalization - Re-admission to hospital - Time to return to work - Late complications: anal stenosis, impaired continence (Wexner Continence Score), recurrence - Re-treatment rates - Need for additional skin tag excision - Quality of life (SF-36 Health Survey questionnaire) - Cost effectiveness

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)